Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries (Nile Pharma) is expecting to achieve a net-profit-before-tax of EGP 153.7 million in the fiscal year 2020/2021.
Revenue is expected to reach EGP 1.1 billion in FY20/21, compared to EGP 740 million in FY19/20, according to a bourse statement released on Thursday.
It is worth highlighting that Nile Pharma reported a net profit of EGP 34.9 million in the six-month period ended 31 December 2019, against net losses of EGP 5.15 million in the year-ago period.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
